CoChat

Declining β-Cell Function Relative to Insulin Sensitivity With Increasing Fasting Glucose Levels in the Nondiabetic Range in Children

Open access
Tfayli, Hala, Lee, SoJung, Arslanian, Silva · 2010 · Diabetes Care

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: In adults, higher fasting plasma glucose (FPG) levels, even within the normoglycemic range, are associated with increased diabetes risk. This investigation tested the hypothesis that β-cell function relative to insulin sensitivity decreases with increasing FPG in youth. RESEARCH DESIGN AND METHODS: A total of 223 youth with FPG <126 mg/dl underwent evaluation of first- and second-phase insulin secretion during a 2-h hyperglycemic (∼225 mg/dl) clamp, insulin sensitivity during a 3-h hyperinsulinemic-euglycemic clamp, body composition, and abdominal adiposity with dual-energy X-ray absorptiometry and computed tomographic scan. β-Cell function relative to insulin sensitivity was calculated as the product of first-phase insulin and insulin sensitivity, i.e., glucose disposition index (GDI). The subjects were divided into three FPG categories: ≤90, >90–<100, and ≥100–<126 mg/dl. RESULTS: GDI decreased significantly across the three categories as FPG increased (1,086 ± 192 vs. 814 ± 67 and 454 ± 57 mg/kg/min, P = 0.002). This decline remained significant after adjustment for race, sex, BMI, and percent body fat or visceral fat. Within each FPG category, GDI declined with increasing BMI percentiles. CONCLUSIONS: The impairment in β-cell function relative to insulin sensitivity is apparent even within the nondiabetic FPG range in children. At the current cutoff of 100 mg/dl for impaired fasting glucose (IFG), there is an ∼49% decline in the GDI independent of obesity and race. This observation may reflect a heightened risk of β-cell dysfunction and progression to diabetes in these children. Considering the near doubling of IFG prevalence among youth between National Health and Nutrition Examination Survey 1999–2000 and 2005–2006, our findings have important public health implications.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc09-2292

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Insulin-stimulated glucose disposal (total, oxidative, and nonoxidative) (A) and insulin sensitivity (B) during the hyperinsulinemic-euglycemic clamp and first- and second-phase insulin levels (C and D) during the hyperglycemic clamp in youth with FPG ≤90 mg/dl (□), >90–<100 mg/dl (), and ≥100–<126 mg/dl (▨). Data represent the estimated marginal means from the ANCOVA model corrected for BMI. P values unadjusted and adjusted for BMI are shown.
Figure 1 Insulin-stimulated glucose disposal (total, oxidative, and nonoxidative) (A) and insulin sensitivity (B) during the hyperinsulinemic-euglycemic clamp and first- and second-phase insulin levels (C and D) during the hyperglycemic clamp in youth with FPG ≤90 mg/dl (□), >90–<100 mg/dl (), and ≥100–<126 mg/dl (▨). Data represent the estimated marginal means from the ANCOVA model corrected for BMI. P values unadjusted and adjusted for BMI are shown.CC BY-NC-ND · PubMed Central
Figure 2 A: GDI (milligrams per kilogram per minute) in youth with FPG ≤90 mg/dl (□), >90–<100 mg/dl (), and ≥100–<126 mg/dl (▨). Data represent the estimated marginal means from the ANCOVA model. ‡Covariates appearing in the model are age, sex, race, Tanner stage, BMI, and VAT. aP = 0.002 when fat mass is added as a covariate to the model; bP = 0.003 when fat mass, lean mass, and height are added as covariates to the model. *P represents post hoc Bonferroni correction. B: GDI (milligrams per kilogram per minute) in youth with FPG ≤90 mg/dl, >90–<100 mg/dl, and ≥100–<126 mg/dl according to BMI <85th percentile (□), between the 85th and 95th percentiles (), and ≥95th percentile (■). P represents ANOVA.
Figure 2 A: GDI (milligrams per kilogram per minute) in youth with FPG ≤90 mg/dl (□), >90–<100 mg/dl (), and ≥100–<126 mg/dl (▨). Data represent the estimated marginal means from the ANCOVA model. ‡Covariates appearing in the model are age, sex, race, Tanner stage, BMI, and VAT. aP = 0.002 when fat mass is added as a covariate to the model; bP = 0.003 when fat mass, lean mass, and height are added as covariates to the model. *P represents post hoc Bonferroni correction. B: GDI (milligrams per kilogram per minute) in youth with FPG ≤90 mg/dl, >90–<100 mg/dl, and ≥100–<126 mg/dl according to BMI <85th percentile (□), between the 85th and 95th percentiles (), and ≥95th percentile (■). P represents ANOVA.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 30 references

Cited by

See all 64

Metadata

Authors
Tfayli, H., Lee, S., & Arslanian, S.
Affiliations
Children's Hospital of Pittsburgh (US)
Corresponding author
Arslanian, Silva
Venue
Diabetes Care
Published
2010-09-01
Volume
33
Issue
9
Pages
2024-2030
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2123147152
Cited by
57
References
30
Citations by year
2025: 1 · 2024: 1 · 2023: 2 · 2022: 3 · 2021: 3 · 2020: 5 · 2019: 2 · 2018: 6 · 2017: 3 · 2016: 1 · 2015: 4 · 2014: 5 · 2013: 9 · 2012: 8
FWCI
7.08
Type
journal article
Language
en
Open access
Locations
  • Diabetes Care (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
  • American Diabetes Association
  • Rural and Environment Science and Analytical Services Division
  • National Institutes of Health (UL1TR000005)
  • U.S. Public Health Service
  • Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston
  • National Institute of Diabetes and Digestive and Kidney Diseases (R21DK083654)
  • National Center for Research Resources (M01-RR-00084, UL1RR024153, M01RR000084)
  • NIH Clinical Center
  • National Center for Advancing Translational Sciences
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01‐HD27503, R01HD027503, K24HD001357, K24 HD 01357)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
beta-cell function, insulin sensitivity, fasting blood glucose, impaired fasting glucose, children, youth, prediabetes, type 2 diabetes risk, hyperinsulinemic-euglycemic clamp, hyperglycemic clamp, body mass index, visceral fat, first-phase insulin secretion
MeSH terms
Adolescent, Adult, Blood Glucose, Body Composition, Child, Fasting, Female, Humans, Insulin Resistance, Male, Glucose Clamp Technique, Absorptiometry, Photon, Adiposity, Insulin-Secreting Cells, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Declining β-Cell Function Relative to Insulin Sensitivity With Increasing Fasting Glucose Levels in the Nondiabetic Range in Children. https://app.cochat.ai/papers/10.2337/dc09-2292
The paper
Tfayli, H., Lee, S., & Arslanian, S. (2010). Declining β-Cell Function Relative to Insulin Sensitivity With Increasing Fasting Glucose Levels in the Nondiabetic Range in Children. Diabetes Care. https://doi.org/10.2337/dc09-2292

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.